Compare Heron Therapeutics Inc (HRTX) vs Yum! Brands, Inc. (YUM) Price & Performance

Heron Therapeutics IncTrade

Yum! Brands, Inc.Trade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Yum! Brands, Inc. — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Yum! Brands, Inc. trades at $148 (market cap $40.62B). The key difference: Yum! Brands, Inc. is far larger — about 444.1× Heron Therapeutics Inc's market cap, and Yum! Brands, Inc. pays a 2.04% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.

	HRTX	YUM
Market Cap	$91.46M	$40.62B
Sector	Health	Consumer Cyclical
52-Week High	$1.96	$168.16
52-Week Low	$0.39	$138.21
Enterprise Value	$189.36M	$51.88B
Dividend Yield	—	2.04%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.

Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.

Yum! Brands, Inc.

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HRTX

View details →

YUM

Yum! Brands faces cyclosporiasis outbreak but impact is mild with no deaths and ongoing recalls.Seeking Alpha · 13 hours agoBearish Taylor Farms recalls iceberg lettuce in 27 states over Cyclospora contamination riskCNBC · 3 days agoBearish Sweetgreen stock jumps 15% after diarrhea outbreak traced to Taco Bell, not salad chainNew York Post · 4 days agoNeutral View details →

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

About Yum! Brands, Inc.

Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.